APEN News and Press, Apollo Endosurgery Inc. From 05/03/22

The following slide deck was published by Apollo Endosurgery, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Apollo Endosurgery, Inc. 2022 Q1 - Results - Earnings Call Presentation

Apollo Endosurgery press release (NASDAQ:APEN): Q1 GAAP EPS of -$0.21 in-line. Revenue of $16.7M (+20.5% Y/Y) beats by $0.77M. For further details see: Apollo Endosurgery GAAP EPS of -$0.21 in-line, revenue of $16.7M beats by $0.77M

Global revenue grew 20% year-over-year as adoption increased across all product lines AUSTIN, TX / ACCESSWIRE / May 3, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announce...

AUSTIN, TX / ACCESSWIRE / April 13, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (Nasdaq:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release financial r...

Veteran Brings 30 Years of Multinational Healthcare Leadership Experience AUSTIN, TX / ACCESSWIRE / April 4, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN) , a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced t...

Apollo Endosurgery (APEN +15.8%) jumps after CFO Jeffrey G. Black bought 40,000 shares of the company, taking his direct beneficial ownership to 2,65,000 shares. At price range of $5.40-$6.30 per share, the transaction values at around $230K. SEC Filing. Quick look at the company's ownership ...

Gainers: Nordstrom (NYSE:JWN) +39%. Arlo Technologies (NYSE:ARLO) +32%. Imperial Petroleum (NASDAQ:IMPP) +30%. Rocky Brands (NASDAQ:RCKY) +27%. Organogenesis (NASDAQ:ORGO) +22%. CytomX Therapeutics (NASDAQ:CTMX) +18%. Prudential Bancorp (NASDAQ:PBIP) +18%. XL Fleet (NYSE:XL) +17%. EPAM System...

AUSTIN, TX / ACCESSWIRE / March 2, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that Chas McKhann, CEO, and Jeff Black, CFO, will host investor meetings March 7-8...

The following slide deck was published by Apollo Endosurgery, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Apollo Endosurgery, Inc. 2021 Q4 - Results - Earnings Call Presentation

Apollo Endosurgery, Inc. (APEN) Q4 2021 Earnings Conference Call February 22, 2022, 4:30 PM ET Company Participants Charles McKhann – Chief Executive Officer Jeff Black – Chief Financial Officer Matt Kreps – Investor Relations Conference Call Participants Eric Assaraf &#x...